IMP is a generic pharmaceutical company in Vietnam with a market share of ~1.4% in 2018, per our estimate based on data from IQVIA – a US market research company. We expect IMP to capture pharma spending growth in Vietnam (8% CAGR over 2019-2022F, per IQV